Abstracts tagged "cross-sectional studies"

Abstract Number: 1530 • 2019 ACR/ARP Annual Meeting
Real World Effectiveness of Secukinumab in Patients with Ankylosing Spondylitis: Findings from a Recent Cross Sectional Survey of Rheumatologists and Patients in Europe
Uta Kiltz ¹, Elizabeth Holdsworth², Haijun Tian ³, Nicola Booth ⁴, Papa Anthony ⁵, Lina Helsche ⁶, Dorothy Keininger ⁶ and Philip G Conaghan ⁷, ¹Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, ²Adelphi Real World, Manchester, England, United Kingdom, ³Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁴Adelphi Real World, Bollington, United Kingdom, ⁵Adelphi Real World, Macclesfield, England, United Kingdom, ⁶Novartis Pharma AG, Basel, Basel-Landschaft, Switzerland, ⁷Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom
Background/Purpose: Ankylosing spondylitis (AS) can lead to reduced physical functioning and quality of life. Secukinumab has demonstrated clinical benefits in AS patients in clinical trials1-2.…
Abstract Number: 565 • 2018 ACR/ARHP Annual Meeting
Genetic Polymorphism in Dihydrofolate Reductase Impacts Methotrexate Polyglutamation in Adult Rheumatoid Arthritis
Thierry Dervieux¹, Marie Grosjean², Chuang Jiang^3,4, Kelley Brady¹, Kjeld Schmiegelow², Joel Kremer⁵ and Jun Yang⁴, ¹Exagen Diagnostics, Inc., Vista, CA, ²University Hospital Rigshospitalet, Copenhagen, Denmark, ³Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China, ⁴Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, ⁵Albany Medical College and The Center for Rheumatology, Albany, NY
Background/Purpose: Methotrexate (MTX) is anti-folate activated to MTX polyglutamates (MTXPGs). MTX metabolism includes multiple enzyme-mediated reactions and genetic polymorphisms in these genes are linked to…
Abstract Number: 638 • 2018 ACR/ARHP Annual Meeting
Diagnostic Delay and Associated Factors in Axial Spondyloarthritis across Europe. Results from the European Map of Axial Spondyloarthritis Survey
Laure Gossec¹, Marco Garrido-Cumbrera^2,3,4, Denis Poddubnyy^5,6, David Galvez-Ruiz^2,4, Christine Bundy⁷, Carlos Jesus Delgado Dominguez^2,4, Raj Mahapatra⁸, Pedro Plazuelo-Ramos³, Souzi Makri⁹ and Victoria Navarro-Compán¹⁰, ¹Sorbonne Universités, Paris, France, ²Health & Territory Research (HTR), Seville, Spain, ³Spanish Coordinator of Spondyloarthritis Associations (CEADE), Madrid, Spain, ⁴Universidad de Sevilla, Seville, Spain, ⁵German Rheumatism Research Centre, Berlin, Germany, ⁶Charité Universitätsmeidzin Berlin, Berlin, Germany, ⁷Cardiff University, Cardiff, United Kingdom, ⁸Ankylosing Spondylitis International Federation (ASIF), London, United Kingdom, ⁹Cyprus League Against Rheumatism, Nicosia, Cyprus, ¹⁰Immuno-Rheumatology research group, IdiPaz. La Paz University Hospital, Madrid, Spain
Background/Purpose: Axial Spondyloarthritis (axSpA) is a chronic inflammatory disease associated with a long diagnostic delay (DD); however, recent data suggests improvements1. The purpose was to…
Abstract Number: 2155 • 2018 ACR/ARHP Annual Meeting
Diagnosis of Systemic Sclerosis in the United Kingdom: An Observational Study Using the Clinical Practice Research Datalink
Alicia Gayle¹, Nils Schoof², Margarida Alves², Deborah Clarke³, Chris Poole¹, Christina Raabe², Prithwiraj Das¹ and Toby Maher⁴, ¹Boehringer Ingelheim Ltd., Bracknell, United Kingdom, ²Boehringer Ingelheim International GmbH, Ingelheim, Germany, ³Department of Medical Affairs, Boehringer Ingelheim Ltd., Bracknell, United Kingdom, ⁴University College London and Royal Brompton Hospital, London, United Kingdom
Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune disease that is characterised by fibroblast dysfunction and excess extracellular matrix deposition that leads to skin thickening and…
Abstract Number: 584 • 2017 ACR/ARHP Annual Meeting
Factors Associated with the “Bamboo Spine” Phenotype – Data from the Comospa Study
Koei Oh¹, Anna Molto², Corinne Miceli-Richard³, Soksay Singvongsa⁴, Adrien Etcheto⁴ and Maxime Dougados⁴, ¹Departmen of Rheumatology, Paris Descartes University, Hôpital Cochin, Paris, France, ²Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, ³Department of Rheumatolgy, Paris Descartes University, Hôpital Cochin, Paris, France, ⁴Department of Rheumatology, Paris Descartes University, Hôpital Cochin, Paris, France
Background/Purpose: The factors associated with “Bamboo spine” occurrence, i.e. the most severe axial phenotype of SpA patients, have been poorly assessed to date. The aim…
Abstract Number: 2194 • 2017 ACR/ARHP Annual Meeting
The Relationship between the Number of Prescription Medications and Physical Activity Amongst Patients with or at High Risk for Knee Osteoarthritis
Nivaas Thanoo¹, Abigail Gilbert², Jing Song³, Dorothy D. Dunlop⁴ and Rowland W. Chang⁵, ¹Feinberg School of Medicine, Chicago, IL, ²Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ³Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁴Inst Hlthcare Studies, Northwestern Univ/ Feinberg, Chicago, IL, ⁵Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: Physical activity amongst individuals with knee osteoarthritis (KOA) has been linked to improved pain, functional status, and less disability. It is important to understand…
Abstract Number: 48 • 2016 ACR/ARHP Annual Meeting
Fibromyalgia Impact Is a Potential Mediator for the Associations of Self-Efficacy and Pain Catastrophizing with Physical Functioning in Persons with Fibromyalgia
Sun Yu¹, Lori Lyn Price², Jeffrey B. Driban¹, William F. Harvey¹ and Chenchen Wang¹, ¹Rheumatology, Tufts Medical Center, Boston, MA, ²Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
Background/Purpose: Fibromyalgia (FM) is a chronic multidimensional disorder that causes physical and psychological impairment, incurring significant healthcare costs. Self-efficacy and pain catastrophizing have been shown…
Abstract Number: 119 • 2016 ACR/ARHP Annual Meeting
Impact of Socioeconomic Status on Disease Outcomes in Japanese Patients with Rheumatoid Arthritis Under the Japanese National Insurance System
Akira Onishi¹, Goichi Kageyama², Yo Ueda², Ikuko Naka², Kosaku Tsuda², Takaichi Okano², Soshi Takahashi², Kengo Akashi², Sho Sendo², Yoshinori Kogata², Jun Saegusa² and Akio Morinobu², ¹Department for Rheumatology, Kobe University Hospital, Kobe, Japan, ²Department of Rheumatology, Kobe University Hospital, Kobe, Japan
Background/Purpose: Several studies showed lower socioeconomic status (SES) was associated with higher disease activity and lower quality of life (QOL) in patients with rheumatoid arthritis…
Abstract Number: 453 • 2016 ACR/ARHP Annual Meeting
Adaptation and Validation the Systemic Sclerosis Quality of Life Questionnaire into Spanish Using Rasch Analysis
Mwidimi Ndosi¹, Silvia Garcia-Diaz², Begonya Alcacer-Pitarch³, Francesco Del Galdo⁴, Vicenç Torrente-Segarra² and Anthony C. Redmond⁴, ¹Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, ²Rheumatology, Hospital Sant Joan Despí Moisès Broggi-CSI-, Barcelona, Spain, ³Leeds Institute of Rheumatic and Musculoskeletal medicine, University of Leeds, Leeds, United Kingdom, ⁴Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom
Background/Purpose: Systemic Sclerosis (SSc) represents a group of heterogeneous autoimmune disorders of connective tissue characterized by progressive fibrosis of the skin and internal organs [1].…
Abstract Number: 1508 • 2016 ACR/ARHP Annual Meeting
Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Sickle Cell Patients: A Cross-Sectional Analysis
David J. Ozeri¹, Joshy Pathiparampil², Randolph Sanchez² and Isabel M. McFarlane³, ¹Rheumatology, SUNY Downstate Medical Center, brooklyn, NY, ²Internal Medicine, SUNY Downstate Medical Center, Brooklyn, NY, ³Rheumatology, SUNY Downstate Medical Center, Brooklyn, NY
Title: Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Sickle Cell Patients Background/Purpose: Rheumatoid arthritis (RA) has been rarely reported in association with sickle cell…
Abstract Number: 2297 • 2016 ACR/ARHP Annual Meeting
Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial
Michael B. Saddekni¹, Angelo L. Gaffo¹, Phillip J. Foster¹, Elizabeth J. Rahn¹, Stephanie R. Biggers¹, Peng Li² and Kenneth G. Saag¹, ¹Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Increased levels of serum urate (sUA) have been reported in association with hypertension, chronic kidney disease, and obesity. All these conditions are over-represented in…
Abstract Number: 2729 • 2016 ACR/ARHP Annual Meeting
Treatment Patterns, Unmet Need, and Impact of Psoriatic Arthritis on Patient-Reported Outcomes in the United States
Alice Gottlieb¹, Jorge Gratacos-Masmitja², April Armstrong³, Jo Lambert⁴, Astrid van Tubergen⁵, Ara Dikranian⁶, Birol Emir⁷, Eustratios Bananis⁸, Tim Smith⁷, Laraine Aikman⁹ and Linda Chen⁷, ¹Tufts University School of Medicine, Boston, MA, ²Servicio de Reumatología, Corporació Sanitoria Parc Taulíde Sabadell, Barcelona, Spain, ³Department of Dermatology, University of Southern California, Los Angeles, CA, ⁴Department of Dermatology, Ghent University Hospital, Ghent, Belgium, ⁵Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ⁶San Diego Arthritis Clinic, San Diego, CA, ⁷Pfizer Inc, New York, NY, ⁸Pfizer Inc, Collegeville, PA, ⁹Pfizer Ltd, Walton Oaks, United Kingdom
Background/Purpose: This non-interventional, cross-sectional descriptive exploratory analysis aimed to characterize patients (pts) with PsA in the 2015 National Health and Wellness Survey (NHWS) and determine…
Abstract Number: 44 • 2015 ACR/ARHP Annual Meeting
The Prevalence of Depression and Anxiety in a Cross-Section of Rheumatological Conditions
Faith Matcham¹, Nicola J. Gullick², Matthew Hotopf³, Sam Norton⁴, Sophia Steer⁵ and James Galloway⁶, ¹Psychological Medicine Clinical Academic Group, King's College London, London, United Kingdom, ²Rheumatology, Department of Rheumatology, King`s College Hospital NHS Foundation Trust, London, United Kingdom, ³Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom, ⁴Institute of Psychiatry, King's College London, London, United Kingdom, ⁵Rheumatology Dept, Kings College Hospital, London, United Kingdom, ⁶Academic Department of Rheumatology, King´s College London, London, United Kingdom
Background/Purpose: Depression and anxiety have detrimental effects on quality-of-life, treatment response and disease outcomes. Whilst psychological morbidity has been described in individual rheumatic diseases, less…
Abstract Number: 2265 • 2015 ACR/ARHP Annual Meeting
Prevalence and Physical and Mental Health Patterns of Rheumatic and Musculoskeletal Diseases in Portugal: Results from a National Health Survey
Jaime C Branco¹, Ana M. Rodrigues², Nelia Gouveia³, Leonor P Costa⁴, Monica Eusebio⁵, Sofia Ramiro^2,4,6, Pedro Machado^4,7,8, Filipa Mourão^4,9,10, Inês Silva^9,11, Pedro Laires⁴, Alexandre Sepriano^4,12, Filipe Araújo^4,13, Sónia Gonçalves⁴, Pedro S Coelho^4,14, Viviana Tavares⁴, Jorge Cerol^4,15, Jorge M Mendes^4,14, Loreto Carmona¹⁶ and Helena Canhao¹⁷, ¹NOVA Medical School/faculdade de ciências médicas, Universidade Nova de Lisboa, Lisboa, Portugal, ²CEDOC - Chronic Diseases FCM NOVA, NOVA Medical School - Faculdade de Ciências Médicas da UNL, Lisbon, Portugal, ³CEDOC - Chronic Diseases FCM NOVA, NOVA Medical School - Faculdade Ciências Médicas da UNL, Lisbon, Portugal, ⁴EpiReumaPt Study Group, Lisbon, Portugal, ⁵Portuguese Society of Rheumatology, Lisbon, Portugal, ⁶Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁷Clínica Universitária de Reumatologia, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, ⁸University College London - MRC Centre for Neuromuscular Diseases,, London, United Kingdom, ⁹Centro Hospitalar Lisboa Ocidental (CHLO- E.P.E.), Lisbon, Portugal, ¹⁰NOVA Medical School - Faculdade Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal, ¹¹EpiReumaPt Study Group, lisbon, Portugal, ¹²Rheumatology, Hospital de Egas Moniz - CHLO, Lisbon, Portugal, Lisbon, Portugal, ¹³Rheumatology, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, ¹⁴NOVA Information Management School, Lisbon, Portugal, ¹⁵Portuguese Catholic University, Lisbon, Portugal, ¹⁶Instituto de Salud Musculoesquelética, Madrid, Spain, ¹⁷Hospital Santa Maria - Serviço de Reumatologia, Lisboa, Portugal
Background/Purpose: Rheumatic and musculoskeletal diseases (MSKD) are a prevalent leading cause of disability and consume a large amount of healthcare and social resources. MSKD have been…
Abstract Number: 2481 • 2015 ACR/ARHP Annual Meeting
Work Disability in a Cohort of Patients with Psoriatic Arthritis
Cecilia Zaffarana¹, Osvaldo Luis Cerda¹, Josefina Gallino Yanzi¹, Margarita Landi¹, Emilce Schneeberger¹, Ignacio Carrillo¹, María del Carmen Gonzalez Guzmán¹, Jose A Maldonado Cocco¹, Susana Gagliardi¹ and Gustavo Citera², ¹Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology, Consultorios Reumatológicos Pampa, Buenos Aires, Argentina
Background/Purpose: Several studies showed that unemployment and work disability are high in patients with Psoriatic Arthritis (PsA). Te purpose of this study is to evaluate work…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].